A small aspirin is now an essential part of Integrative cancer treatments

A small aspirin is becoming an essential part of cancer treatment and the Francis Crick Institute has shown that aspirin reduces inflammation around the cancer cell, acting like an immunotherapy and stopping the cancer hiding from the immune system, as reported on CANCERactive.

John Vane won a knighthood and a Nobel Prize for showing how good a small aspirin was in reducing inflammation caused by Cox-2, and enzyme that exists all over the body. The Mayo Clinic also showed the benefits (75 mg in the UK; 81 mg in America. Then Oxford University and te Radcliffe completed a six-year research study showing a small aspirin increased survival and greatly reduced metastases. 

There is just so much evidence now that suggests a small aspirin should be an important part of cancer treatment programmes.Integrative